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1. Introduction 
 
1.1. Definitions 
Epilepsy isa disorder of the brain characterised by an enduring predisposition to generate 
epileptic seizures and by the neurobiological, cognitive, psychological, and social consequences 
of this condition. The definition of epilepsy requires the occurrence of at least one epileptic 
seizure. An epileptic seizure is a transient occurrence of signs and/or symptoms due to abnormal 
excessive or synchronous neuronal activity in the brain (International League Against Epilepsy 
(ILAE), International Bureau for Epilepsy (IBE) (1). 
   Intractable epilepsy or drug-resistant epilepsy is defined as failure of adequate trials of 
two tolerated, appropriately chosen and used antiepileptic drug schedules (whether as 
monotherapies or in combination) to achieve sustained seizure freedom. This definition can be 
further refined when new evidence emerges. (ILAE, 2010) (2). Epilepsy affects 3 % of the 
general population all over the world. People with epilepsy suffer from brain damage resulting in 
neurological deficit. Further, it leads to changes in social, occupational and behavioural aspects 
of individuals suffering from epilepsy causing devastating economical consequences. All the 
more it is obvious that these consequences are significant in patients with intractable epilepsy. 
 
1.2.    Prevalence and incidence of intractable epilepsy 
In India, the prevalence of epilepsy is reported to be around 5.35/1000, estimated by the 
meta-analysis of 20 Indian published and unpublished studies (3).  Prevalence estimates are 
reported to be more in rural areas (5.47) than urban areas (5.11) also epilepsy is more in men 
(5.88) than women (5.11) per 1000 population (3). Most of the studies carried out for prevalence 
studies were based on door-to-door survey, random survey, screening instruments, and World 
Health Organization protocols (4). In western countries prevalence of intractable epilepsy in 
adults was reported to be 5.4 per 1000 population (5) which comparable to that of our 
population.   Despite the influx of new Antiepileptic drugs over the past 10 years the incidence of 
intractable epilepsy is reported to be high around 20-40% with newly diagnosed epilepsy (6). 
There are several studies in western population to address the prevalence of intractable 
epilepsy. Due to the discrepancies in the terminologies (drug resistant epilepsy, intractable 
epilepsy, etc.) and criteria for subject selection, the comparison between the prevalence of 
intractable epilepsy across various studies was difficult. Recently the prevalence of intractable 
epilepsy was reported by two studies in Italy (7) and Singapore (8) using drug-resistant epilepsy 
criteria (ILAE, 2010).    In India, there are no such studies available using drug-resistant epilepsy 
criteria (ILAE, 2010), especially in adults. The prevalence of intractable epilepsy was reported to 
be ranging from 20 to 30% among patients with epilepsy in south India (9).  
 
1.3.    Predictors of intractable epilepsy 
There are various predicators of intractable seizures in India was reported by Tripathi et 
al among 200 patients. On univariate analysis they observed age of onset of seizure before 
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fourteen years, partial seizures, presence of neurological deficits, perinatal insult, delayed 
milestones, history of CNS infection, febrile seizures, high initial seizure frequency of more than 
one per month, non-response to first Anti-Epileptic Drug and abnormal brain imaging as 
predictors for intractable epilepsy. On multivariate analysis significant predictors reported were 
radiological evidence of structural cerebral abnormality, non-response to first AED, delayed mile 
stones, high initial seizure frequency of more than one per month, partial seizure type, febrile 
seizures and age of onset before fourteen years (10). In western countries, high seizure, neonatal 
seizure, birth injury, epileptic encephalopathy, early breakthrough seizure, neonatal status 
epilepsy as a first attack, structural damage due to birth trauma, neuronal migration disorders are 
the predictors of intractable epilepsy (11).  
 
1.4.    Types of seizures and its clinical characteristics 
International League Against Epilepsy (ILAE) has appointed a Task Force to formulate a 
consensus on the definition of drug resistant epilepsy and have classified into two hierarchy 
levels. Level 1 provides a general scheme to categorise response to each therapeutic intervention. 
Level 2 provides a core definition of drug resistant epilepsy using a set of essential criteria based 
on the categorization of response (from Level 1) to trials of antiepileptic drugs (2).  
Berg et al (2010) have modified the concepts, terminologies and approaches in classification and 
terminology in epilepsy at International League against Epilepsy (ILAE) Commission (12). 
Epilepsy is classified as generalised seizures, focal seizures or Unknown as to whether focal, 
generalised, or depending on context. Generalised seizures are further classified as tonic-clonic, 
absence, myoclonic and clonic-tonic atonic (12). 
 
1.5.    Etiology of refractory seizure 
Various causes have been reported in the literature. Malformations of cortical 
development, Head injury, Cerebrovascular disorders, CNS infection, pre and perinatal factors, 
CNS malformation, chronic alcoholism, encephalopathy, multiple causes, cerebral tumour, 
Degenerative diseases, autoimmune diseases, calcification, gliosis, cerebral atrophy, and other 
causes are often associated with intractable epilepsy. Epilepsy in the study group was caused by 
perinatal problems (48%) and sequelae of central nervous system infection (24%) and was 
idiopathic in 20% (13). ILAE commission recommends using terminologies Genetic, structural-
metabolic, and unknown to represent and replace idiopathic, symptomatic, and cryptogenic 
causes of epilepsies (12). 
 
1.6.    Pathophysiology of intractable seizure 
Most of the patients suffering from epilepsy of various types respond to antiepileptic 
drugs and they are completely free from developing attacks. But still 30 % of epileptic patients 
continue to develop recurring attacks of seizures in spite of adequate and appropriate 
antiepileptic drug therapy. The definite mechanism underlying this state is not clearly 
understood. Hence various hypotheses have been postulated. They are target hypothesis, 
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transporter hypothesis, gene variant– inherent severity hypothesis and neural network hypothesis 
(14).  
 
1.7.    Hypothesis for intractability  
Target hypothesis 
     It explains how acquired structural and functional alteration at the target ion channels and 
neurotransmitter receptors lead to intractable seizure (15). Most of the Anti epileptic drugs 
(AEDs) act on targets of voltage-gated cation channels (α subunits of voltage-gated Na+ 
channels and T-type voltage-gated Ca+ channels) and also the influence of the gamma amino 
butyric acid (GABA-mediated inhibition) are very important to increase inhibitory potential. 
 
Transporter hypothesis 
    Transporter hypothesis states that the distribution, metabolism and elimination of antiepileptic 
drugs depend on the pharmacokinetic process by which the drug reaches the appropriate target 
regionsand this is very important. This, pharmacokinetics of antiepileptic drug is being 
controlled by special proteins such as p glycoprotein, breast cancer resistance protein and multi 
drug resistance protein secreted at the cellular wall and are genetically determined. These are 
drug efflux transporters from the ATP binding cassette (ABC super family). The up-regulation of 
this system leads to reduced bioavailability of Anti epileptic drug at the epileptic zone leading to 
intractable epilepsy (16).  
 
Intrinsic severity hypothesis 
    Inherent severity disorder is the determinant of the treatment outcome. For example number of 
attacks in the early phase of the illness/disease leads to intractable seizure which may be due to 
factors operating extracellular and intracellular level (intrinsic and extrinsic mechanism) genetic 
basis (17) has a role in this mechanism. 
 
 
Network Hypothesis 
Neural network hypothesis state that “seizure-induced alterations of brain plasticity 
including axonal sprouting, synaptic reorganization, neurogenesis and gliosis could lead to the 
formation of abnormal neural network, which has not only avoided the inhibitory effect of 
endogenous antiepileptic system but also prevented the traditional antiepileptic drugs from 
entering their targets, eventually leading to intractable epilepsy” (18).  The above changes lead to 
adaptive remodelling of the neural structures after the attack of seizure may lead to permanent 
epileptic neural circuit causing intractable epilepsy. Brain function is a result of the activity of 
neural network connecting cortical and subcortical systems. Epilepsy is a dynamic disease of this 
neural network. When the normally functioning brain jumps to another state causes abnormal 
oscillation resulting in epilepsy and lasts for few seconds to minutes and returns to normal state. 
From the review of literature 2 systems appear to be involved in displaying epileptic behaviour: 
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1)   Thalamocortical system  is a pacemaker in generalised epilepsy 
2)   Mesial temporal system  is involved in temporal lobe epilepsy 
By studying these hypotheses, refractory epilepsy is complex and multi-factorial. Single 
hypothesis or multiple hypotheses may be operating in a given intractable epilepsy patient.  
Acquired or genetic background or both may be important in studying patient with intractable 
epilepsy. Understanding the above hypothesis is very important to do research in developing 
newer drugs and non-pharmacological ways to treat the drug-resistant epilepsy effectively. 
 
1.8.    Structural abnormalities in intractable epilepsy 
1.8.1.    Computerised tomography and Magnetic resonance imaging  
Computerised tomography (CT) and Magnetic Resonance imaging (MRI) are routinely 
used in epilepsy to identify various congenital and structural abnormalities in the brain. CT can 
accurately detect haemorrhage, infarctions, gross malformations, ventricular system pathologies, 
and lesions with underlying calcification (19).  The sensitivity of CT in patients with epilepsy is 
not higher than 30%.  CT has overall a low sensitivity and poor resolution in the temporal fossa, 
thus CT is not useful in detecting mesial temporal sclerosis, the most common pathology in 
intractable temporal lobe epilepsy (20). The sensitivity of MRI is high in detecting abnormalities 
in patients with epilepsy such as Mesial temporal sclerosis (MTS), small tumours, trauma and 
developmental malformations (21–23). 
 
1.8.2.    Malformation of cortical development 
Malformations of cortical development (MCD) are microscopic and macroscopic 
development abnormalities of the cerebral cortex that arise due to an interruption in cortical 
development during fetal development by genetic or environmental factors(24). According to 
Barkovich classification MCDs have classified into three groups 1) malformations due to 
abnormal neural proliferation, 2) malformations due to abnormal neuronal immigration, and 3) 
malformations due to the abnormal cortical organization (25). Due to improved technology in 
Magnetic Resonance Imaging (MRI) used with patients with epilepsy a forth group of 
Malformations of cortical development, not otherwise classified is added to Barkovich classical 
classification.  
There are very few studies in the literature regarding the prevalence of MCD in drug-
resistant epilepsy. The prevalence of MCD reported being high in children with drug-resistant 
childhood epilepsy ranging from 25% to 40% (21,23,26). In adults, the prevalence of 
intractability among patients with MCD is reported to be 84.8% (27) in a large series of patients 
with epilepsy (N=3000). With recent advancement in radiological imaging techniques, the 
identification of MCD has increased significantly (24,28–31). Studies carried out among MCD 
population revealed several developmental anomalies like focal cortical dysplasia, 
Polymicrogyria, Lissencephaly, heterotopias, dysembryonicneuroepithelialtumour, 
Hemimegalencephaly and others (28,30,32). Clinical features of MCDs are often heterogeneous. 
MCD exhibit seizures majorly complex partial seizure, to any other form of seizures (27,30), 
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family history (27,30), usually drug resistant and intractable(27,28), change in semiology (29), 
associated with febrile seizures (30), present with delayed motor or mental milestones (30,32), 
cognitive defects and learning disability (27,32). About a third of patients with MCD had 
hippocampal abnormalities like the hypoplastic hippocampus, hippocampal sclerosis, malrotated 
hippocampus, and enlarged hippocampus(32). Febrile seizures with Focal Cortical Dysplasia 
(FCD) are reported to have dual pathology (FCD with hippocampal sclerosis) (29).  
 
1.8.3.    Incomplete-hippocampal inversion 
Incomplete hippocampal Inversion (IHI) is a failure of hippocampal inversion that occurs 
during normal fetal developmentand can be diagnosed with MRI and often reported to be 
pathological in patients with seizures (33). Recent studies on patients with temporal lobe 
epilepsy (TLE) and MCD have reported that IHI can be found in a similar proportion of MCD 
and TLE (34). An excellent study by Bajic et al, have shown that IHI is observed in 30% of 
patients with epilepsy mostly on the left side followed by bilateral and right sided IHI(35). The 
presence of IHI has been reported to be a marker of a more extensive disorder of brain 
development (34,35). With the evidence of having IHI as a malformation of brain development, 
it would be a possible abnormality causing intractable epilepsy. 
 
1.8.4.     Mesial temporal sclerosis  
The most common pathology seen in patients with intractable temporal lobe epilepsy is 
Mesial Temporal Sclerosis (MTS). MTS is pathologically characterised by the presence of 
atrophic hippocampus, increased signal on T2-weighted images or FLAIR (fluid-attenuated 
inversion recovery) and decreased signal on inversion recovery sequences (36–38). Brain 
abnormalities especially MTS, either alone or in association with another lesion are major 
predictors of intractable epilepsy (39). MTS is classified histopathologically into three types 
namely, type 1a (classic hippocampal sclerosis involving severe cell loss in CA1 and moderate 
loss in other subfields except CA2), type 1b (severe hippocampal sclerosis involving severe cell 
loss in all hippocampal subfields), type 2 (atypical hippocampal sclerosis involving severe 
neuronal loss restricted to CA1) and type 3 (atypical hippocampal sclerosis involving severe 
neuronal loss restricted to hilar region)(40).  Early brain insult (trauma, febrile seizures) is called 
as initial precipitating injury could lead to hippocampal damage resulting in type 1A, 1B 
pathology. In type 2 and type 3 the initial precipitating injury is reported to as result of late insult 
to the hippocampus(40). After initial precipitating injury, most of the damaged cells in the 
hippocampus (inhibitory function) remain silent, but the dentate gyrus granule cell layer and its 
axons (mossy fibres) sprout into the molecular layer andis excitatory in function. After sprouting 
there is an excitation and inhibition mismatch leading to increased excitation resulting in 
recurrence of seizure with a change in seimiology(41). The observation supports the concept that 
extensive bilateral hippocampal circuit rewiring leads to intractability in temporal lobe epilepsy 
patients (42).  
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T1 and T2 weighted images less than 3mm cuts will help us to evaluate hippocampus. 
The Smaller size of the hippocampus in intractable epilepsy is suggestive of hippocampus 
sclerosis on the affected side. Increase T2 signal in the hippocampus suggestive of gliosis. 
Gradient echoes help to identify vascular lesions. Flurodeoxy glucose positron emission 
tomography (FDG –PET) is a useful test in pre-surgical evaluation of patients suffering from 
temporal lobe epilepsy. Hypo metabolism in the temporal lobe ipsilateral to the seizures focus is 
a positive predictor for good outcome after epilepsy surgery. Hence it is useful only in people 
who are subjected to epilepsy surgery. In the genetic form of temporal epilepsy, images studies 
will be normal. In lateral or neo cortical epilepsy, Lesions like malformation of the cortical 
development, vascular malformation, encephalomalacia secondary to trauma, inflammation, 
ischemia, haemorrhage and tumour are seen. 
 
1.8.5.    Vascular lesions  
Most frequently encountered vascular causes of intractable epilepsy is arteriovenous 
malformations (AVMs) and cavernomas(43). In a large sample, 30% of AVMs are reported to be 
associated with a seizure. Most of the AVMs were reported to be located in temporal and 
rolandic region presenting with partial epilepsy, where as frontal or Sylvian region AVMs were 
presenting with generalised seizures. 24.7% of patients with partial epilepsy were reported to be 
intractable.(44). The severity of the seizure depends on the size of AV malformation, 
haemorrhage and fronto temporal location (45). Delay in the intervention leads to structural 
abnormalities of the brain, namely hemi-atrophy of the brain. 
 
1.8.6.    Tumors 
Intractable epilepsy associated with tumours often present with focal epilepsies. 
Glioneuraltumours most commonly arise from the temporal lobe. Studies on a large sample (N= 
207) of patients underwent surgical resection of tumour associated with intractable epilepsy 
showed 154 patients with classic epilepsy-associated tumours 
(dysembryoplasticneuroepithelialtumour, ganglioglioma, and pilocyticastrocytomas) and 53 
others tumors (astrocytomas and oligodendrogliomas) (46). Also, cortical dysplasia and other 
neuronal migration disorders often coexist with these tumours. These are all drug resistant 
epilepsy and amenable to surgical therapy(47).  
 
1.8.7.    Post-traumatic epilepsy 
Several studies have reported the incidence of post-traumatic epilepsy from 7-31.9% 
following brain injury  (48,49). Closed traumatic brain injuries often cause brain parenchymal 
haemorrhage, necrosis, oedema and white matter lesions (50). Injury to neurons causes cellular 
loss with gliosis, changes in neuronal plasma membrane, sodium and potassium ionic channels 
leading to increased excitation of cells resulting in epilepsy (51,52). 
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1.8.8.     Infections and epilepsy 
Brain infections are reported to be the significant contributors of epilepsy by crossing 
blood brain barrier and causing neuronal loss. Recent studies suggest that subjects with chronic 
infections are susceptible to epileptogenesis and intractability of seizures. Due to epilepsy, 
evidence for inflammation of nerve cells are demonstrated by post-surgical studies (53) , 
hippocampal sclerosis (TLE)(54),  Rasmussen's encephalitis (55), tuberous sclerosis(56)  and 
antiepileptic effect of anti-inflammatory drugs in west, Landau Kleffner syndromes, Lennox–
Gastau syndromes(57). 
 
1.8.9.    Post-stroke epilepsy 
Stroke is the one of the common neurological disorder that can be often associated with 
epilepsy and adds on to the disability and increase complexity for treatment. Several studies have 
reported that seizures may occur approximately up to 10% of patients following stroke (58,59). 
Individuals with stroke may present with early seizure or late seizures following stroke (ILAE, 
1993). Seizures are reported to be often associated with hemorrhagic strokes than ischemic 
stroke. Complex partial seizures are often reported to be present with early seizures whereas 
generalised tonic-clonic seizures are reported to be associated with late seizures after 2 weeks 
(59,60).  Acute Metabolic dearrangementsassociated with stroke cause early seizures that can be 
reversed. In contrast Late seizures cause structural changes like gliosis or meningocerebral scar 
tissue (61). Changes in the cell membrane, neuronal loss and collateral sprouting are reported to 
cause excitation in epilepsy (62). Cortical infarction is most often reported to be resulting in 
seizure rather than subcortical involvement (63). Large cortical infarction (64) especially the 
involvement of temporal lobe are often reported to be a high-risk factor for developing post-
stroke seizures. 
 
1.8.10.    Calcification     
Calcification occurs in the brain due to various factors like infections (toxoplasmosis, 
rubella, cytomegalovirus, cysticercosis, AIDS), calcium metabolism disorders, genetic(Cockayne 
syndrome, tuberous sclerosis, Fahr’s disease, down syndrome, and neurocutaneous syndrome 
like storage weber’s syndrome) or autoimmune disorders ( autoimmune encephalitis) and 
persistent inflammation. Focal cortical – subcortical calcifications are reported to be associated 
with focal or generalised epilepsy especially in India. 77.5% of patients with calcifications are 
reported to have focal epilepsy(65). Basal ganglia calcifications are often associated with 
hypoparathyroidism and pseudohypoparathyroidism. Intracranial calcifications are also 
considered as incidental in 0.3 to 1.5% of the patients (66).  Calcification due to infections may 
be associated with perilesionaloedema. These patients have the tendency to develop seizures 
intermittently. The pathophysiology of the perilesionaloedema is not clearly understood but it 
may be due to post ictaloedema or release of ionic calcium (67). Focal cerebral calcifications in 
CT scan are reported to be associated with gliosis around the calcified lesion on T1 weighted 
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MRI images. 33.3% of patients with perilesionalgliosis is reported to be have increased seizure 
frequency and they were drug resistant (68).  
 
1.8.11.     Metabolicdisorder 
Intractable epilepsy due to metabolic disorder is not rare in adults. The metabolic 
disorders may be due to small and large molecule disorders. Small molecule disorders include 
defective molecule or mechanisms related to amino and organic acids, fatty acids, 
neurotransmitters, urea cycle, vitamin cofactors, and mitochondria. Large molecule disorders 
include defective molecules and mechanisms related to lysosomal storage disorders, peroxisomal 
disorders, glycosylation disorders, and leukodystrophies. Epileptic encephalopathies are inborn 
metabolic defects that present with intractable epilepsy. They may present with intractable 
neonatal seizures, early myoclonic encephalopathy, early infantile epileptic encephalopathy, 
infantile spasms, and generalised epilepsies and in particular include myoclonic seizures (69). 
These disorders are reported to be rare in the adult population.  
 
1.9.    Diffusion Tensor weighted imaging 
Diffusion Tensor Weighted Imaging (DTWI) is a recently developed MRI technique, 
which has gained importance over time to assess abnormalities with focal epilepsy (70–72). 
DTWI measures the molecular motion of water in tissue in various directions in every voxel, 
providing information regarding the microstructure of the white matter & grey matter, cellular 
packing, cellular loss or regional oedema in focal status epilepticus (73).  In DTWI, Apparent 
Diffusion Coefficient (ADC) and Fractional Anisotropy (FA) are the commonly recorded tensor 
measured in structural MRI (74,75).  Diffusion tensor weighted images have been studied well 
on a small group of individuals with temporal lobe epilepsy (TLE) and extra-temporal lobe 
epilepsy (ETLE). Interictal DTWI imaging studies are reported to be more sensitive in 
identifying hippocampal involvement rather than conventional MRI in TLE (76). Interictal 
imaging studies in patients with medial temporal lobe epilepsy associated with hippocampal 
sclerosis showed diffusion abnormalities involve a pathologic hippocampus and larger network 
involvement (77). Diffusion tensor imaging in patients with epilepsy and MCD have shown 
changes in tissues beyond the areas of MCDs and appeared normal on conventional MRI (78). 
Patients with partial seizures and normal MRI findings showed various areas with abnormal 
anisotropy or diffusion, which were normal in conventional MRI (79). The Interictal study of 
patients with normal structural MRI and TLE shows bilateral and extratemporal lobe 
involvement (72). In TLE, lateralization of the epileptogenic region using DTWI studies highly 
correlates with the presence of unilateral hippocampal sclerosis on conventional MRI (80).  In 
patients with non-lateralizing conventional MRI findings, the interictal DTWI studies will not 
provide lateralizing information (76). From the review of the literature, there is ample evidence 
of DTWI image abnormalities unilaterally or bilaterally when MRI studies of the brain are 
normal or abnormal.  
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1.10.   Volumetric studies of hippocampus 
Incomplete hippocampal Inversion (IHI) is a failure of hippocampal inversion that occurs 
during normal fetal development, which can be diagnosed with MRI and often reported to be 
pathological in patients with seizures (33). Recent studies on patients with temporal lobe 
epilepsy (TLE) and MCD have reported that IHI can be found in a similar proportion of MCD 
and TLE (34). An excellent study by Bajic et al, have shown that IHI is observed in 30% of 
patients with epilepsy mostly on the left side followed by bilateral and right sided IHI(35). The 
presence of IHI has been reported to be a marker of a more extensive disorder of brain 
development (34, 35). With the evidence of having IHI as a malformation of brain development, 
it would be a possible abnormality causing intractable epilepsy. 
 
1.11.    Neuropsychological manifestations in epilepsy 
The psychiatric manifestations of psychosis, depression, anxiety and other behavioural 
disturbances can coexist with intractable epilepsy but sometimes they may manifest as a part of 
seizure or they may be due to drugs (81–84). The psychiatric manifestations may worsen the 
existing epileptic condition. Gross impairment of cognition may be due to continuous seizure and 
drugs (83–86). Mood disorders, personality change, Attention deficit hyperactive disorders, 
language disorders are also associated with epilepsy (83, 84, 87, 88) 
Anxiety and depression often coexist in individuals suffering from epilepsy (81,88–92). 
The prevalence of anxiety ranges from 11 to 25% and depression range from 9 to 40% in persons 
with epilepsy across various studies when compared to individuals without epilepsy. The 
prevalence of anxiety and depression is often reported to be higher in individuals with drug 
resistant epilepsy and temporal lobe epilepsy (82, 87, 93–96). Depression and anxiety have been 
also reported to be often associated with suicide, suicidal ideation and suicidal attempt (97–99). 
Altogether anxiety and depression in patients with epilepsy affect quality of life (100–102).  
Most important cognitive deficit in Temporal lobe epilepsy (TLE) patients, especially in 
patients with mesial temporal sclerosis, is memory impairment (103,104). Weschler's memory 
scale -III and Weschler's adult intelligent scale –Revised can differentiate patients with refractory 
temporal lobe epilepsy from normal subjects but they cannot differentiate between the right and 
the left TLE (104). Also, other factors including long-term antiepileptic drugs, the age of onset, 
duration of epilepsy, types of seizure also contribute to cognitive defects over the years 
(105,106). 
 
1.12.    Electroencephalography 
Interictal Electroencephalography (EEG) in patients with intractable seizure shows 
generalised abnormality in 75% of the cases rest of the EEG show focal epileptiform activities, 
which correlate with their clinical conditions (107). In Focal cortical dysplasia, interictal routine 
video EEG were reported to show regional epileptic activity in 89% of patients (108). When 
compared to routine EEG, intensive EEG monitoring was reported to be useful in detecting 
epileptic activity in patients with intractable epilepsy (109).  
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Interictal electroencephalography (EEG) findings in MTLS – spike and sharp waves are 
seen over the anterior temporal region. Sleep deprivation sometimes activates focal epileptic 
form of discharges. Therefore EEG with sleep recordings is recommended during diagnostic 
workup. The presence of mid and posterior temporal lobe spikes in EEG may suggest a 
widespread involvement of epileptic network. Even in the presence of normal medial temporal 
lobe, ictal EEG may reveal rhythmic, alpha or beta activity and evolve to rhythmic delta or theta 
activity. The seizure discharge may be limited to a medial temporal lobe or it may spread to 
ipsilateral hemisphere and contralateral temporal lobe. Unilateral temporal lobe slowing in EEG 
is suggestive of ipsilateral seizure onset. Interictal EEG pattern was almost same in neocortical 
epilepsy as seen in medial temporal epilepsy. But abnormal waves like spikes or sharp waves are 
seen over T4, T3 and T6, T5and rapidly propagates to other lobes and quickly spread to opposite 
side. Polymorphic delta pattern is also seen over above-said areas. Dorsolateral and frontopolar 
epilepsies will be associated with focal epileptiform activity because the electrodes placement 
will be very easy. Foci arising from inter-hemispheric, orbitofrontal cortex and frontal opercular 
cortex cannot be recordable because of the difficulty in placing electrodes. The frontal lobe is 
very near to temporal lobe, so epileptic form of activity can also recorded in the anterior 
temporal electrodes. Bilateral secondary hyper-synchrony has also described in patients with 
frontal lobe epilepsy. The epileptic form discharges appear as generalised spikes, polyspikes or 
spike and wave. It is always differentiated from frontal lobe epilepsy by locating unilateral 
epileptic form discharges before the generalised discharges. 
 
Need for the study and hypothesis 
From the review of the literature, studies using drug-resistant epilepsy criteria (ILAE, 
2010) to identify its prevalence and clinical characteristics are sparse, especially in Indian 
context. There are few studies in India regarding the prevalence of intractable epilepsy (13,107) 
and its risk factors (10). They report various risk factors that contribute for intractability in the 
epileptic population. Identification of various risk factors responsible for intractability is reported 
to be associated with significant therapeutic implications. Several studies in western countries 
and in India identify various structural abnormalities like mesial temporal sclerosis, 
malformations of cortical development, vascular lesions, stroke, traumatic brain injury, 
calcification and infections as a cause for intractability and accounts for 60-70% of the 
population.  30-40% of them do not show any lesions/ malformations still they exhibit intractable 
epilepsy. With the advancement of technology especially DTWI, volumetric studies it would be 
possible to identify microstructural abnormalities and asymmetries that would contribute to 
intractable epilepsy. Identifying structural abnormalities or multiple lesions using various 
investigations would help up in tracing the neural network responsible for epilepsy.  
In developing countries like India, where accessibility to neuroimaging facilities are not 
easily accessible the prevalence of intractable epilepsy and various structural lesion associated 
with them is largely unknown. There are few preliminary studies carried out in India to 
document frequency and clinical characteristics of MCD among children (30,110) and adults 
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(30). Their studies are carried out retrospectively especially from the case records of the epileptic 
population (30). Also little is known about the prevalence of Mesial temporal sclerosis and 
incomplete hippocampal inversion in the Indian context. Studies in Indiausing Diffusion tensor 
weighted images (111) were reported to be useful in identifying white matter structural 
abnormality among extratemporal epilepsy patients. DTWI is also reported to be helpful in 
predicting the postoperative neurological outcome, surgical decision-making and preoperative 
counselling of patients. 
Moreover, it has been reported that structural abnormalities would give rise to focal 
seizures and may be the temporal or extratemporal type. Correlating the type of epilepsy, the age 
of onset, duration of seizure, status epilepsy, clustering and Electroencephalography finding with 
structural lesions of the brain would guide us in predicting the possible clinical manifestations of 
those lesions. Also, intractable epilepsy associated with various structural lesions may present 
with various profiles of neuropsychological manifestation. Identifying the neuropsychological 
profile for each structural lesion would help us to approach clinically for further investigations 
and treatment planning. Intractable epilepsy being one of the important disorders causing 
disability, correlating structural abnormalities with demographic data and quality of life would 
reveal the psychosocial aspects of the patients  
To obtain seizure freedom from the recurring and debilitating seizures understanding the 
mechanism involved in epilepsy, identify neural networks and its clinical manifestation is 
essential. Surgical, medical management and rehabilitation measures are important to control 
seizures and improve the quality of life.  This can have a great impact not only on psychosocial 
aspects of patients and their family but also reflect on the country’s economy. So the present 
study was carried out to identify various structural lesions using different radio imaging 
techniques including CT scan, MRI, DTWI and volumetric studies and correlate with 
demographic data, medical history, seizure examination, neurocognitive profiles and EEG. 
 
 
2.    AIMS AND OBJECTIVES 
 
2.1.    Aims 
To investigate the prevalence, demographics, clinical characteristics, psychological 
status, radio imaging findings and EEG in patients with intractable epilepsy 
 
2.2.    Objectives 
 
1.    To estimate the prevalence of intractable epilepsy in an adult who attend epilepsy clinic, 
Institute of neurology, Rajiv Gandhi Government General Hospital. 
2.    To assess the educational, occupational status, clinical characteristics, psychological status, 
EEG and structural abnormalities in patients with intractable epilepsy 
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3.    To compare type of seizure (generalized and partial seizures) in adult intractable epilepsy 
patients with demographic (age, gender, occupational status, educational level), clinical 
characteristics (developmental history, natal history, postnatal history, family history, age of 
onset, duration of seizure, seizure frequency, clustering, precipitating factors, status epilepsy, 
neuro examination, comorbid conditions and Drug), psychological assessment (Intelligent 
quotient (IQ), Mental quotient (MQ), Bender-Gestalt test (BGT), depression and anxiety scores), 
radio imaging findings (Computerized tomography (CT) scan, Magnetic Resonance Imaging 
(MRI), Diffusion Tensor Weighted Imaging (DTWI)) and  Electroencephalography  
4.    To associate the type of structural lesions in MRI with the demographics, clinical 
characteristics, psychological assessment and EEG findings. 
5.    To associate side of abnormality across various neuroimaging investigation (CT, MRI, 
DTWI) and EEG with the type of seizure. 
6.    To assess the sensitivity of each radio imaging techniques (CT, MRI and DTWI) or in 
combination (CT &MRI, MRI and DTWI) to identifying structural lesions. 
 
 
3.    METHOD 
A prospective study was carried out to investigate prevalence, demographics, clinical 
characteristics, psychological status, radioimaging structural abnormalities and EEG in subjects 
with intractable epilepsy. Subjects who fulfilled the Drug resistant epilepsy criteria defined by 
ILAE were considered for the present study. A cohort of 600 patients with intractable epilepsy 
was considered for data collection over a period of 3 years from 21-09-11 to 20-09-14. Prior to 
the study ethical committee clearance was obtained from the local ethical committee in Madras 
Medical College, Letter No.  40062011 dated 24-06-201. Collection of data was carried out after 
getting informed written consent (Tamil) from all participants.  
The present study was carried out in four phases. 1) Screening for intractable epilepsy 
using Drug-resistant epilepsy criteria (ILAE, 2010), 2) Data collection from the previous medical 
records, case history and Neurological examination, 3) follow-up and review of a patient after 
radio imaging investigations and interictal EEG recordings 4) follow-up and review of patients 
after neuropsychological assessment.  
 
Phase 1: During the period of 3 years (from 21-09-11 to 20-09-14) at the epilepsy clinic, 
Department of Neurology, Institute of Neurology, Rajiv Gandhi Government Hospital, Chennai a 
total of 2850 patients were screened to identify patients with intractable epilepsy. Among the 
patients who fulfilled the inclusive and exclusion criteria’s, 600 patients were randomly selected 
for data collection. 
 
Phase 2: All the participants underwent detailed data collection from previous medical records, 
case history and Neurological examination. Medical records seen over the period ranging from 5 
to 20years were obtained from the patient. Case histories were obtained from the patient or 
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caregivers with the procedure as mentioned in the methodology. Also, all patients underwent 
neurological examination under the direct supervision f the researcher himself. All the data 
collected were entered into a personalcomputer using software designed for entering data. 
 
Phase 3: Following neurological examination the intractable epilepsy patients were referred to 
the radiology department for neuroimaging studies (CT, MRI and DTWI). The protocols used for 
each test were described in methodology. Interictal EEG recording was done after neuroimaging 
investigations at our department. All the tests in phase 3 were carried out within 3 to 6 months 
after enrolment of each patient. All the patients were reviewed and neuroimaging findings were 
entered into the computer.  
 
Phase 4: Neuropsychological evaluations like (Intelligent quotient (IQ), the mental quotient 
(MQ), Bender-Gestalt test (BGT), anxiety and depression scales) was carried out by experienced 
clinical neuropsychologist within 2- 3 months of radiological investigation. All the patients were 
reviewed with neuropsychological reports and data collected were entered into the computer and 
all statistical analyses were carried out using the well known statistical package IBM SPSS 
(version 21) software. 
 
3.1.    Participants 
 
600 intractable epilepsy patients with the following inclusion and exclusion criteria were 
considered as a cohort group for the present study. 
 
Inclusion criteria: 
1.    Patients who fulfilled the criteria of Drug-resistant epilepsy defined by ILAE (2) were 
considered for the present study. 
2.    Patients in the age range of 10years to 70 years were considered for the study     
Exclusion criteria: 
1.    Patients with poor drug compliance were excluded from the present study. 
2.    Patients with Alcohol addiction and substance abuse were not considered 
3.    Patients should not have a pseudo seizure. 
 
3.2.    Material and Procedure 
 
3.2.1.    Case history 
Detailed Case history evaluation was done using direct one to one clinical interview and 
questionnaire. The questionnaire contained set of questions to collect information regarding 
demographic data, family history, prenatal, perinatal and postnatal history. The questionnaire 
was administered by the clinician to the patients or caregivers at the outpatient department in 
epilepsy clinic. If the patients have severe cognitive impairment the questionnaire was 
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administered to the caregivers. Demographic data included Patient record number, Name, Age, 
gender, address, contact number, educational status and occupational status. Following details 
were collected under Medical history, prenatal history, natal, post natal history, developmental 
history, family history, patient habits (alcohol, smoking, and substance abuse), sleep disturbance, 
behavioural changes, cognitive impairment and neuropsychological manifestation. 
 
3.2.2.    Neurological examination 
Neurological examination included collecting information about seizure from previous 
medical records, description of seizure by patients or caregivers and direct observation of 
patients. The information collected include data about Seizure type, Onset of seizure, Duration of 
seizure, Seizure semiology and changes, Neurocutaneous markers, Frequency of seizure, 
Clustering, Precipitating factors, Status epilepsies, Hemiplegia, Migraine headache and Trauma  
 
3.2.3.    Neuroradiological investigations 
Neuroradiological investigations included CT scan, MRI scan, diffusion tensor weighted 
imaging (DTWI) and hippocampal volumetric studies. All the neuroradiological investigations 
were carried out by an experienced neuroradiologist and identified structural abnormalities in the 
brain. All CT, MRI, DTWI, volumetric studies images and reports were collected and the 
information’s were entered for the corresponding patients. Following protocols were used to 
collect data from each radiological investigation. 
 
3.2.3.1.    CT scan protocol 
All the subjects underwent conventional CT scan assessment using 16 slices CT scanner 
system (Seimens, Germany). Axial sections were taken using the following protocol: 1. Scout: 
Lat (Length 350) Breath Hold: None 2. Axial: 5mm x 5mm Recon: 5mm x 5mm Bone 3. FOV: 
250 4. Scan Length: angled to the base of the skull through the top of the skull. 
3.2.3.2. MRI protocol 
All the subjects underwent conventional MRI and DTWI imaging on a 1.5T, 48 channel System 
(SeimensAera, Germany) using a head coil (40 elements), Gradient strength of 45mT & flow rate 
of 200 Mt/sec. MRI protocol consisted of axial T1 weighted sequence (T1), axial T2 weighted 
sequence (T2) and volumetric T1 weighted MRI (3D – SPGR) sequence. These images were 
analysed by experienced neuroradiologists who detected the MCDs and hippocampal 
malformations. 
3.2.3.3. DTWI and hippocampal volumetric study Protocol 
DTWI was performed in the axial plane by using single-shot echoplanar imaging with the 
following parameters: TR/TE, 3500/83 ms; diffusion-gradient encoding in 20 directions; b0, 
1000 s/mm2; FOV, 230 X 100 mm; matrix size, 128 X 128; section thickness, 5 mm; bandwidth- 
1500, EPI factor- 128 average - 3 and number of signals were acquired. Standard DWI acquires 
data in three orthogonal planes (typically X, Y, and Z axis). 
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The acquisition was repeated with gradients oriented in each of the 3 directions in space. With 2 
acquisitions with different b-factors (typically b = 0 and 1000 s/mm2), it becomes possible to 
calculate the apparent diffusion coefficient (ADC) without the T2. While ADC maps reveal the 
tendency of the water molecules to diffuse within a voxel, directional variation is also required to 
image 3D anisotropic diffusion. The complex mathematical equation used to model 3D 
anisotropy is called tensor. 
By sampling a minimum of 6 or more diffusion directions and establishing a relationship 
between the acquired data and applied diffusion gradients in the pulse sequence, the directional 
variation in the tendency of water molecules to diffuse within a voxel was imaged. FA- fractional 
anisotropy, geometric tensor metrics (linear anisometry-Cl, planar anisometryCp, and spherical 
anisometry- Cs), and ADC- apparent diffusion coefficient, RA- relative anisometry , GA- 
Geodesic anisometry were calculated by using the standard algorithms respectively. Images were 
transferred to a separate multi-modality workstation (Siemens MMWP) - Neuro 3D software for 
post processing. 
In addition to the above, MR data was also obtained on a separate cohort of controls and patients 
on a 3T Siemens Spectra scanner: a T1 weighted structural axial MPRAGE sequence was 
performed to obtain high resolution structural data. The voxel dimensions were 0.98 mm x 0.98 
mm x 1mm. DWI images with an isotorphic voxel dimension of 2mm x 2mm x 2 mm was 
obtained with 64 gradient directions at a B value of 1000. Reference volumes with B = 0 were 
also obtained. 
Maps of FA and ADC were calculated at the various region of interest especially in 
Frontotemporal fasciculus, frontoparietal fasciculus, temporoparietal fasciculus, 
temporooccipital fasciculus, parietooccipital fasciculus, uncinate fasciculus, hippocampal and 
parahippocampal region, fornix and fimbrae, cingulate gyrus to identify various tracts or regions 
which are involved in maintenance of normal brain function. 
3.2.4.    EEG investigations 
Routine Scalp EEG recording was performed using Nicolet EEG system (Natus, USA) 
during the interictal period. Electrodes were placed on the scalp using 10-20 classification 
systems. EEG was recorded using 25 channels. Waves were amplified and filtered with low pass 
filter with a high cutoff of 70Hz and high pass filter with a low cutoff of 1Hz. Sensitivity used 
were 70micorvolt/ cm with a time base of 30mm/sec. EEG was recorded during awake time, eye 
opening and eye closure, Photic stimulation, sleep deprivation and hyperventilation. 
 
3.2.5.    Neuropsychological Assessment 
After neuroradiological investigations, the clinical neuropsychologist assessed the 
patients for psychological functions. Neuropsychologist was blinded to the type of structural 
abnormalities in the brain. All of the neuropsychological assessments were carried out in a quiet 
room and well-lit room. Initially, Bender Gestalt test (BGT) was administered. If patients were 
able to perform the task in BGT, the Intelligent quotient (I.Q) and Memory quotient (M.Q) 
assessment were carried out. If the I.Q were greater than 70, scales to evaluate anxiety, 
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depression and quality of life were administered. Whenever patients were not able to perform 
BGT or could not perform any task, or low IQ less than 70, scales to evaluate anxiety and 
depression and quality of life scale were not administered. The following neuropsychological 
tools were used to assess each patient 1) Bender Gestalt test to assess visuoperceptual gestalt 
functions, 2) Weschler's children or adult intelligence scale to assess intelligence quotient, 3) 
Weschler memory quotient to assess memory quotient 4) Multiphasic personality questionnaire 
to assess anxiety and depression and 5) WHO quality of life Brief (WHOQOL – BREF) 
questionnaire to assess quality of life scores in all four domains namely physical health, 
psychological, social relationship and environment. World health organisation quality of life 
scale was used in the present study to estimate the quality of life in 4 domains (physical health, 
psychological health, social relationship and the environment. Scores in each domain ranged 
from 0 to 100. 147 patients who had mental retardation were considered as having a poor quality 
of life. Scores less than or equal to 50 were considered as a poor quality of life and scores greater 
than 50 were considered as a good quality of life. Total quality of life scores ranged from 0 to 
120. Scores were classified into 4 categories 1) very poor (mentally retarded group), 2) poor 
scores less than or equal to 60, 3) scores between 61 and 90 & 4) scores between 91- 120.  
 
3.3.    Statistical Analysis 
Out of 600 patients with fulfilled the criteria for drug-resistant epilepsy (ILAE, 2010) 
only 506 patient returned back with complete information regarding the medical history, neuro 
radio imaging reports, interictal EEG findings and neuropsychological assessment reports. Thus 
506 patients with a complete set of data were included in the study for further analysis. The data 
collected from intractable epileptic patients were carefully coded and entered into a personal 
computer.  All statistical analyses were carried out using the specially designed statistical 
software package, IBM SPSS (Version 21).  Some of the statistical analyses carried out for the 
present study include formation of frequency tables – one way, two way and multiway - with 
percentages; summary statistics such as mean, standard deviation etc. For qualitative data 
analyses, non-parametric tests and for quantitative data analysis parametric was used.  In all the 
tests, the significance level was kept at, α = 0.05. 
 
 
4.    Observation 
 
4.1.    Prevalence of intractable epilepsy 
The present study estimated prevalence of intractable epilepsy using drug-resistant 
epilepsy criteria (ILAE, 2010). Out of 2850 patients (1523 males and 1327 females) seen at our 
epilepsy clinic, 600 (21.05%) patients fulfilled the criteria for drug-resistant epilepsy. Patients 
who completed all the investigation were 506 patients -  294 (58.1%) males and 212 (41.9%) 
females. From the present study at out epilepsy clinic, the prevalence of intractable epilepsy is 
reported to be 21.05% that approximates 1 in 5 patients with epilepsy.  
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4.2.    Demographics of patients with intractable epilepsy 
Demographic details collected from patients with intractable epilepsy showed the 
distribution of patients across the age, gender, education and occupation. Most of the patients 
with intractable epilepsy were observed commonly in the age range of 16-20 years (24.11%), 
followed by 26-30 years age range (16.60%). Decreased prevalence was observed in the age 
range >60 years (1.38%).  
Educational status of patients with intractable epilepsy shows most of the patient's 
literacy is high school level (38.54%) and elementary school level (32.21%). 16.8% of them 
were illiterate and had no school education. Though major literacy level of patients with 
intractable epilepsy was high school and elementary level, high frequency of unemployment 
(36.96%) was observed in patients with intractable epilepsy. Only a few proportion of the 
population were skilled workers (13.24%), in clerical jobs (3.36) and professional jobs (1.58%). 
A significant proportion of patients (13.64%) were underemployed who were working as daily 
labour.  34.9% of females in the intractable epilepsy group were housewives. 33.81% of patients 
with intractable epilepsy less than 25 years of age were graduates and high school students. 
 
 
4.3.    Clinical characteristics of patients with intractable epilepsy 
4.3.1.    Type of seizure 
The major type of seizure that caused intractability is partial seizures (n = 369, 72.92 %,) 
followed by generalized seizures (n=137, 27.08%). In partial epilepsy 312 patients had complex 
partial seizures, 50 patients had a simple partial seizure and 7 had mixed type of seizures and 
constitute 63.04%, 9.88% and 1.38% of the total patients with intractable epilepsy respectively. 
In generalised epilepsy, 121 patients had generalised tonic clonic seizures and 16 patients had 
myoclonic epilepsy whichconstitutes 23.91% and 3.16% of the total patients with intractable 
epilepsy. In our series of 506 patient’s absence seizures was not observed.  
 
4.3.2.    Duration seizure 
Most of the patients (77.07%) in our study had seizure duration ranging from 1-20years. 
Seizure duration (greater than 21years) was observed in less proportion of patients (22.92%) with 
intractable epilepsy.  
 
4.3.3.    Onset of seizure 
From the present study, it was observed that most of the patients who had intractable 
epilepsy had early onset of seizure i.e. less than 5 years of age (30.24%, n=153).  The age of 
onset of seizure decreased with increase in age range. The number of patients slightly decreased 
as the age of seizure onset increased from 21-25years. Later the percentage of patients with 
intractable epilepsy decreased with increasing age range.  
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4.3.4.    Seizure frequency 
Most of the patients with intractable epilepsy had seizure frequency of 1-4 times per 
month (54.35%, n=275), followed by 1-6 times per week (29.84%,n=151) and daily seizure 
occurrence (15.81%, n=80). 
 
4.3.5.    Seizure semiology 
Seizure semiology change was observed from the clinical records. Majorly seizure 
semiology changed from generalised to complex partial seizure and also from simple partial to 
complex partial seizures in 329 patients (65.02%). These changes in seizure semiology occurred 
1-5years after the onset of an initial seizure.  
 
4.3.6.    Clustering 
Clustering of seizure was not observed in 296 patients (58.5%) with intractable epilepsy. 
Clustering was reported to be present for 1-2 times in 145 patients (28.66%), 2-3 times in 44 
patients (8.70%) and greater than three times in 21 patients (4.15%).  
 
4.3.7.    Precipitating factors 
Many patients in our study population had sleep deprivation as precipitating factor 
(15.42%, n=78), followed by other factors (4.15%,n=21), sleep (3.16%, n=16) and febrile illness 
(1.98%, n=10). The patients or caregivers did not report any precipitating factors for their illness 
is 75.30% of the population (n=381). Other precipitating factors include loud sounds and light 
(cinema, watching TV and working as a welder). 
 
4.3.8.    History of Status epilepsy 
History of Status epilepsy was reported in 42 patients (8.30%) of the population. 
 
4.3.9.    Drugs  
Most of the patients with intractable epilepsy were under polytherapy (84.78%, n=429). 
15.22% (n=77) of them were under monotherapy. All the patients were treated with one or more 
of the following drugs (carbamazepine, sodium valproate, phenobarbitone, and phenytoin 
sodium). 
 
4.3.10.    Co-morbid conditions 
The major comorbidity of epilepsy in the present study is a migraine and accounts for 
14.03% (n=71), followed by stroke (3.36%, n=17), head injury (2.37%, n=12) and smoking 
(<1%).  
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4.3.11.    Medical history 
In the birth, history asphyxia was reported to be present in 4.15% (n= 21) of the 
population. Postnatal febrile seizures were observed in 1.98% (n=10), followed by 6 patients 
(1.19%) with infections, 5 patients (.99%) with the head injury, and 4 patients (.79%) with 
hypothyroidism and 3 patients (n=3) with infantile stroke. Delayed motor developmental 
milestones were reported to be present in 73 patients that constitute 14.43% of the population. 
 
4.3.12.    Family history 
Positive family history for seizure was reported to be present in 34 patients (6.72%) of 
the population studied. 
 
4.3.13.    Neurocutaneous markers 
Neurocutaneous markers like adenomasebaceum, hypomelanosis of Ito, 
neurofibromatosis and Sturge-weber syndrome were observed in our case series. A total 10 
patients with intractable epilepsy (1.98%) had neurocutaneous markers and associated structural 
abnormalities in the brain. 6 patients with adenomasebaceum, 2 patients with neurofibromatosis, 
one patient with hypomelanosis of Ito, and one with Sturge-weber syndrome.  
 
4.3.14.    Neurological examination  
Headache (19.96%, n=101) and hemiparesis (3.36%, n=17) were often present in patients 
with intractable epilepsy during neurological examination. 
 
4.3.15.    Electroencephalography findings 
Interictal EEG showed generalisedepileptiform discharges in 40.71% (n=206) of the total 
population. Focal epileptiform discharges were observed in 80 patients (15.81%) with intractable 
epilepsy. Out of 80 patients with focal EEG activity, 25 patients were from the right hemisphere 
and 55 patients from the left hemisphere. 220 patients (43.48%) in spite of their seizure 
intractability showed normal interictal EEG. 
 
4.4.    Neuroimaging results in patients with intractable epilepsy 
4.4.1.    CT scan findings 
In the present study, several investigations were carried out systematically to evaluate 
lesions in the brain among patients with intractable epilepsy. 388 (76.68%) patients with 
intractable epilepsy did not show significant abnormalities of the brain in CT scan. The lesions 
most commonly observed in participants with intractable epilepsy were calcification (10.47%, 
n=53), followed by atrophy (5.34%, n=27), gliosis (4.15%, n=21) and infarction (1.98%, n=10). 
Non-neoplastic cysts, neoplastic and lissencephaly were rarely observed in patients with 
intractable epilepsy us CT investigations. The majority of lesions were bilateral (12.06%, n=61) 
especially calcifications. Following bilateral lesions left sided lesion were common than right-
sided lesions. 
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4.4.2.    MRI findings  
Most common abnormality (32.02%, n=162) that was observed in patients with 
intractable epilepsy wasMesial temporal sclerosis (MTS). Following MTS, non-specific lesions 
that include cortical atrophy, periventricular white matter calcifications were commonly 
observed in 15.61% (n=79) of the population. Neoplastic and nonneoplastic lesions including 
gliosis, cyst, vascular malformations, Hemorrhage and infective lesions were observed in 
12.06% (n=61%). Malformations of cortical development were observed in 9.88% (n=50) of 
patients with intractable epilepsy. Incomplete hippocampal inversion was observed in 35 patients 
with intractable epilepsy that constitute 6.92% of the total population studied. Commonly, 
lesions were observed on left side (35.57%, n=180), compared to bilateral (23.52%, n=119) and 
right-sided lesions (17.39, n=88). 119 (23.52%) patients with intractable epilepsy did not show 
any abnormalities in 1.5Tesla MRI. 
 
4.4.2.1.    Mesial temporal lobe sclerosis  
Mesial temporal sclerosis was most commonly observed in the left side (18.37%, n=93) 
compared to the right side (8.30%, n=42). Bilateral MTS was observed in 27 patients (5.33%). 
Also, MTS were associated with malformation of cortical development, gliosis, non-specific 
cystic lesions, infarction, and incomplete hippocampal inversion in 28 patients (5.53%). These 
lesions were categorised under multiple lesions.  
 
4.4.2.2.    Incomplete hippocampal Inversion  
Hippocampal malrotation or incomplete hippocampal inversion (IHI) were identified in a 
small proportion of patients with intractable epilepsy using hippocampal volumetric studies. Out 
of 509 patients, 35 patients had incomplete hippocampal inversion and constitutes 6.92% of the 
total population. IHI was commonly observed in left hippocampus (n=30) compared to the right 
hippocampus (n=5). Three patients who had IHI also presented with FCD were categorised under 
multiple pathologies. 
 
4.4.2.3.    Malformations of cortical development  
Several malformations of cortical development were observed in 506 patients with 
intractable epilepsy. MCD were grouped into the following categories as summarised in table 1. 
 
4.4.2.4.     Neoplastic and non-neoplastic lesions  
Neoplastic lesions were observed in two patients. One patient with glioma and another 
patient with gliomatosisceribri. Inflammation and Infections like herpes simplex encephalitis 
with granuloma (1 patient), tuberculousmeningoencephalitis (2 patients), neurocysticercosis 
(1patient) and Hashimoto’s autoimmune encephalitis (1 patient) were observed in 5 patients with 
intractable epilepsy.  Gliosis at various regions of the brain especially peritoocipetal and 
orbitofrontal regions was observed in 29 (5.70%) with intractable epilepsy signifying nonspecific 
lesion secondary to trauma, ischemia and inflammation. Intractable epilepsy associated with 
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Infarctions was observed in 12 patients (2.37%). Most of the patients had infarction at the left 
hemisphere, especially in the parietooccipital region.  Arteriovenous malformations (AVM) were 
associated with focal intractable epilepsy with secondary generalisation in 6 patients (1.18%). 
All of them had AVM at the parietotemporal region. 2 patients with intractable epilepsy 
presented with haemorrhage in the brain (.39%). 
 
4.4.2.5.    Non-specific lesions  
Idiopathic focal cortical atrophy was observed in 11 patients (2.2%). Calcification (focal 
calcification, multiple calcifications (small and large)), calcification with gliosis and 
calcifications with perilesionaloedema were observed in 68 patients (13.43%). 
Table 1:Various malformation of cortical development observed in 506 patients with 
intractable epilepsy 
Various Malformation of 
cortical development 
Frequency (n=50) Percentage 
Focal cortical dysplasia 
Frontal lobe                       Right  
                                           Left 
                                           
Bilateral 
Temporal lobe                   Right 
                                           Left 
                                           
Bilateral 
Parietal lobe                       Right 
                                           Left 
                                           
Bilateral 
Occipital lobe                    Right 
                                           Left 
                                           
Bilateral 
Multiple FCD 
 
26 
3 
5 
1 
1 
4 
2 
- 
1 
1 
1 
 1 
- 
5 
 
5.13 
 
 
 
 
 
 
  
Pachygyria 1 .19 
Polymicrogyria 2 .39 
Dysembryonicneuroepithelial 
tumor 
2 .39 
Heterotopia 4 .79 
Lissencephaly 2 .39 
Schizencephaly 2 .39 
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4.4.3.    DTWI findings 
Diffusion tensor weighted images (DTWI) showed increased FA (fractional anisotropy) 
values and decreased ADC (apparent diffusion coefficient) values in one or several regions in the 
brain among the various regions interest considered for the present study.  DTWI were 
significantly abnormal in 406 (80.23%) intractable epilepsy patients. 158 (31.23%) patients 
showed left sided abnormality followed by bilateral (30.24%) and right-sided (17.39%) 
abnormality. The areas of interest considered for the present study were Frontotemporal 
fasciculus, frontoparietal fasciculus, temporoparietal fasciculus, temporooccipital fasciculus, 
parietooccipital fasciculus, uncinate fasciculus, hippocampal and parahippocampal region, 
thalamus, corpus callosum, fornix and fimbriae and cingulate gyrus. 217 patients especially 
patients with MTS showed abnormal DTWI values in hippocampal and parahippocampal 
regions. Also, abnormal ADC and FA values were observed in higher frequencies at middle 
cerebellar peduncle, uncinate fasciculus, temporooccipital fasciculus, temporoparietal fasciculus, 
fimbriae, fornix, thalamus and corpus callosum. Also, the involvement of cingulate gyrus,  
parietooccipital fasciculus, frontoparietal fasciculus were less commonly observed in the patient 
with intractable epilepsy. 
 
4.5.    Neuropsychological assessment findings in patients with intractable epilepsy 
Out of 506 patients with intractable epilepsy, 147 patients (29.05%) had mental 
retardation (<69) score in Weschler intelligence scale. 20% (n=104) of them had dull normal 
intelligence. 255 patients (50%) of them had adequate intelligence. Weschler's memory quotient 
scores were low (<70) in 194 patients (38.34%). Bender Gestalt test revealed abnormal 
visuoperceptual gestalt functions in 218 patients (43.08%). Multiphasic personality questionnaire 
to assess anxiety and depression could not be administered in 147 patients who had mental 
retardation. Multiphasic personality questionnaire administered to patients without mental 
retardation showed anxiety in 161 patients (31.82%), depression in 142 patients (28.06%) and 
mixed anxiety and depression in 126 patients (24.90%). A Higher proportion of intractable 
epilepsy patients had a poor quality of life in a social relationship  (36.17%) followed by 
psychological health, environment and physical health domains. Most of the patients with 
intractable epilepsy had the poor and very poor quality of life scores in all the four domains. 
 
4.6.    Comparison of type of seizure with demographics, clinical characteristics, structural 
imaging and neuropsychological assessment findings of intractable epilepsy 
Pearson’s Chi-square test was applied to the data to find the association between the type 
of seizures with the demographics, clinical characteristics, structural imaging and 
neuropsychological findings. Pearson’s chi-square test revealed a significant association between 
the patient age group and type of seizure. Generalised seizures were significantly (p<0.05) 
associated with 16-20 years, 26-30 years and 31-35 years age groups. The partial type of seizures 
had the strong association (p<0.05) with the age ranges between 16 years to 40 years. 
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No significant association (p>0.05) was observed between the type of seizure and other 
demographic variables like gender, occupational status and educational level.  Clinical 
characteristics (developmental history, natal history, postnatal history, family history, the age of 
onset, duration of seizure, seizure frequency, precipitating factors, status epilepsy, comorbid 
conditions and Drugs) did not show any association with the type of seizure in our population.  
The majority of patients with intractable epilepsy type of seizure were not associated with 
clustering (p<0.05). But a few proportion of patients (34.42%, n=127) in partial seizure group 
had a significant association with the clustering of 1-2 times. In the neurological examination, 
none of the comorbid conditions except a postictal headache had an association with the type of 
seizures. Partial type of seizures had a strong association with a headache in 23.31% of the 
population (p<0.05). Seizure semiology change was observed significantly in a high proportion 
(68.02%) of patients with partial seizures followed by generalised seizure (56.93%).  
CT scan findings did not reveal significant results with the both type of seizures (p<0.05). 
Both the type of seizures showed strong association with MTS, Neoplastic and Non-neoplastic 
lesions (gliosis, cyst, vascular malformed, infectious) and non-specific lesions (p<0.05). 39.02% 
of patients with partial seizure were significantly associated with MTS when compared to 
generalise seizure (13.14%). 19.71% of patients with generalised seizures had non-specific 
lesions when compared to 14.09% of patients with partial seizures. Neoplastic and non-
neoplastic lesions were observed almost in equal proportion among patients with generalised 
(13.87%) and partial seizures (11.38%). 38.69% patients with generalised seizure had 
statistically significant normal MRI findings. DTWI findings showed a significantly higher 
proportion of abnormalities in 85.09% of patients with complex partial seizures followed by 
67.15% of patients with generalised seizures. DTWI findings were significantly normal in 
32.85% of patients with generalised seizures.  
Interictal EEG findings were significantly normal in both the type of seizures (p<0.05). 
49.64% patients with generalised seizures and 41.19% with partial seizures had normal EEG 
results. Focal epileptiform discharges in 20.05% of patients with partial seizures. Focal 
epileptiform discharges were rarely observed (4.38%) in patients with generalised seizures. 
45.99% of patients with generalised epilepsy had bilateral epileptiformgeneralised discharges 
followed by 38.75% of patients with partial seizures. 
Neuropsychiatry findings and type of seizures were compared using Pearsons Chi- Square test. A 
comparatively similar proportion of patients with the generalised seizure and partial seizure had 
low IQ and mentally retarded, reduced MQ, abnormalities in BGT, anxiety and depression and 
quality of life. Pearsons Chi-Square test did not reveal any significant difference between the IQ, 
MQ, BGT, anxiety, depression and quality of life scores between the generalised and partial 
seizure. 
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4.7.    Association of type of structural lesion with demographics, clinical characteristics, 
neuro radio imaging and neuropsychological findings  
 
4.7.1.    Structural abnormalities and their demographics in intractable epilepsy 
 
Patients with structural abnormalities and without structural abnormalities were 
compared to find the association with demographic details. There was no association observed 
between the type of structural lesion and the demographics such as age, education level and 
occupational status except gender (p>0.05) as seen in the table. Male being more in our study 
population showed a significant increase in the frequency of structural lesions. 
 
4.7.2.    Association of Clinical characteristics with structural abnormalities in intractable 
epilepsy 
 
There was no significant association between the structural abnormalities and the clinical 
characteristics (medical history and seizure characteristics) of intractable epilepsy patients. The 
clinical characteristics associated with structural lesions were natal history and postnatal history, 
developmental history, family history, Seizure type, Onset of seizure, Duration of seizure, 
Seizure semiology changes, Neurocutaneous markers, Frequency of seizure, Clustering, 
Precipitating factors, Status epilepsies, neurological examination, comorbid conditions and 
drugs. Even though there were significant p values in neurocutaneous marker, family history, the 
age of onset of a seizure, clustering, neurological examination and comorbid condition using chi-
square test, many of the cells had frequencies less than 5, thus they were not considered as 
significant measures. 
 
 
4.7.3.    Association of structural abnormalities with radio imaging findings 
The side of the lesion in CT, MRI, DTWI and EEG were associated with various 
structural lesions using chi-square test. The side of the lesion in MRI was significantly associated 
with MTS (right and left lesions) and bilateral nonspecific lesions. The side of the lesion in 
DTWI was significantly associated with MTS (right, left and bilateral lesions). CT scan findings 
were associated with neoplastic- non-neoplastic lesion (right and left) and nonspecific lesions 
(right, left and bilateral) but the results were not considered significant due to 10% of cells has 
expected frequencies less than 5. The side of the lesion in EEG was associated with MTS (right 
and left), but the results were not considered significant due to 10% of cells has expected 
frequencies less than 5.  
 
4.7.4.    Neuropsychological manifestations of structural abnormalities in intractable epilepsy 
Abnormal IQ scores (below average), MQ scores, BGT results were strongly associated 
(p<0.01) with MTS. The significant proportion of patients with intractable epilepsy who had no 
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structural abnormalities had normal I.Q scores, M.Q scores and BGT results.  The significant 
proportion of patients with MTS had anxiety and depression. Also, a significant proportion of 
patients without any structural abnormalities did not show any signs of anxiety or depression.  
Another significant proportion of patients with MTS had combined symptoms of anxiety and 
depression (P<0.05). 
Total quality of life was very poor in MCD, MTS, neoplastic and non-neoplastic, 
nonspecific lesions and patients without any structural abnormalities. For these patients, IQ and 
MQ were severely impaired.  16.33% of MCD patients fell into the very poor quality of life and 
rest of them did not show a significant association of other categories of quality of life. IHI 
patients did not show any association between quality of life. Other individuals with MTS, 
Neoplastic and Non-neoplastic lesions, Nonspecific lesion and patients without any structural 
abnormalities showed heterogeneity in the quality of life scores. A significant proportion of 
patients with the above-mentioned lesion fell into very poor, poor, average and good quality of 
life scores. 
 
4.8.    Association of side of lesion across neuroimaging investigation (CT, MRI, DTWI) and 
EEG  
 
4.8.1.    Association of side of lesion in CT vs MRI investigations  
Out of 506 cases, 115 cases were found to be normal without any structural lesions in 
both CT and MRI. Out of 388 patients who had normal CT results 273 patients had abnormal 
results in MRI (right-sided lesion (66), left sided lesion (139) and bilateral lesions (68). Out 95 
patients who had an abnormality in both CT and MRI, 18 of them were found to have a lesion on 
the right, 29 of them were found to have a lesion on the left, and 48 of them were found to have a 
bilateral lesion.  Hence the consistency of CT and MRI results in our study is 
(115+18+29+48)/506 (*100) = 41.5%. If CT and MRI results of patients were combined 
ignoring patients without structural abnormalities, then the consistency is (18 +29+48)/115 
(*100) = 82.6% or nearly 83 %.  In other words, both CT and MRI imaging showed the same 
side of a lesion in more than 80% of patients. 
4.8.2.    Association of side of lesion on MRI and DTWI 
From the present study, it was observed that a significant proportion of patients who have 
normal MRI showed significant DTWI abnormalities (left and bilateral hemispheres of the 
brain). A significant proportion of patient with right hemisphere MRI lesions showed right and 
bilateral hemispheric abnormalities in DTWI as seen in table 21.  Similarly, a significant 
proportion of patients with left hemispheric lesions in MRI showed left or bilateral hemispheric 
lesions. Also, a significant proportion of patients who showed bilateral lesions in MRI showed 
bilateral abnormalities in DTWI. The consistency of MRI and DTWI results in our study is [(54 
+ 103 +68)/ (79 +129+125)] * 100 = 67.57% 
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4.8.3.    Association of side of lesion between MRI and EEG 
A significant proportion of patients without Structural lesion in MRI (61.3%), right 
(43.2%) or left (37.8%) or bilateral (34.5%) abnormalities in MRI did not reveal any 
abnormalities in EEG. Also, one third of patients (34.5%) without structural abnormalities in 
MRI did show bilateral epileptiform discharges from both hemispheres. Patients with right-sided 
abnormalities in MRI showed significant EEG abnormalities in the right hemisphere (25%) and 
bilateral hemispheres (28.4%). Similarly, patients with left hemispheric lesions in MRI showed a 
significant amount of EEG abnormalities in left (25%) and bilateral hemispheres (36.7%). 
Bilateral lesion often showed significant bilateral EEG abnormalities in 62.2% of the population. 
The consistency of MRI and EEG results in our study is [(22+45+74)/ (23+52+165)] * 100 = 
58.75%. 
 
4.8.4.    Association of side of lesion between DTWI and EEG 
Patients who had normal DTWI finding, 24% showed significant bilateral EEG 
abnormalities and 64% of them did not show any EEG abnormalities. The significant proportion 
of patients who had right or left or bilateral hemispheric abnormalities in DTWI significantly 
showed bilateral EEG abnormalities as seen in table 23. The consistency of DTWI and EEG 
results in our study is [(19+34+95)/ (22+46+182)] * 100 = 59.2%. 
 
4.9.    Role of Neuroimaging results (CT, MRI and DTWI) and EEG in identifying structural 
lesions 
CT scan results have a greater chance in identifying non-specific lesions (40.7%) and 
neoplastic - nonneoplastic lesions (29.7%). Altogether CT scan has 70% chance to identify 
neoplastic - nonneoplastic lesions or non-specific lesions. MRI results have a higher chance 
(41.9%) identifying MTS. Similar to MRI, DTWI also has a greater chance of detecting an 
abnormality in MTS (36.7%). EEG revealed abnormal result in MTS and is a form of focal 
lesion associated with CPS. Among MCD, MRI had higher sensitivity when compared to CT 
scan. 
None of the imaging techniques used could identify any abnormalities in 6.13% (n=31) of 
patients with intractable epilepsy. Interestingly, DTWI could identify an abnormality in 7.91% 
(n=40) of patients with intractable epilepsy apart from all other investigations. If MRI and DTWI 
were combined for investigating intractable epilepsy patients, the frequency of identifying 
structural abnormalities increased to 18.58% (n= 94). If MRI, DTWI and interictal EEG were 
combined it could identify abnormalities in 30.24% (n=153). If all the four investigations 
showed consistent abnormality in 12.85% (n=65) 
 
4.10.    Association education and occupation in intractable epilepsy 
Chi square test was applied to associate education and occupational levels in intractable 
epilepsy. Occupational status were grouped into 1) unemployed (unemployed + housewife), 2) 
Employed (daily labour, skilled, clerical, professional) and 3) Students for analysis. Intractable 
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epilepsy being a heterogeneous group (cognitive functions, structural abnormalities) showed 
varied level of educational status and occupation. Patients without any school education 
(63.53%), elementary level of education (65.64%) and high school level of education (46.67%) 
were significantly associated with unemployment. Also 31.28% of population with high school 
education and 42.86% of populationwith a graduate level of education were significantly 
associated with employment.   
 
4.10.1.    Factors contributing to education in patients with intractable epilepsy 
Chi-square test was applied to find out the association of demographic variables, 
structural abnormalities and psychological variables that contribute to education and 
unemployment in patients with intractable epilepsy. A significant proportion of patients 
(41.18%) who had a younger age of onset of seizure had no school education followed by 
29.45% of them having an elementary level of education. Also, longer duration seizures (16-20 
years) had a significant proportion of association with no schooling (30.59%) and elementary 
level of education (20.25%). The equal proportion of patients with longer duration of seizure had 
significant association across all the education level. 91.76% of them who were under 
polytherapy had no schooling and 88.96% of them who were under polytherapy had education 
up to elementary level. The various structural lesion, radio imaging techniques, side of lesion 
across various radio imaging techniques and EEG did not associate significantly with any 
category of education being considered for the study. 48.24% and 12.94% of the population who 
had low IQ scores had no school education.  High IQ scores were associated with the graduate 
level of education in 73.02% of the population. 85.71% and 65.64% of them who had normal 
MQ scores fall undergraduate and high school education category. 55.29% and 43.56% of 
patients who had low MQ scores have not undergone any school education and studied the only 
elementary level of education respectively. 71.43% of the population with normal BGT results 
significantly correlated with the graduate level of education. 58.82% and 48.47% of the 
population who had abnormal BGT scores were uneducated and had the only elementary level of 
education. An equal proportion of patients with anxiety, depression, and mixed anxiety 
depression symptoms fall in elementary, high school and gradual level of education. 
 
4.10.2.    Factors contributing to occupation in patients with intractable epilepsy 
Among clinical characteristics duration of seizure (longer than 16-20years) was 
significantly associated with unemployment. Patients who had a younger age of onset (6-
10years) had a significant association with employment. Almost equal proportion of patients 
with intractable epilepsy for who did not have an episode of status epilepsy were unemployed, 
employed and student which indication no association of status epilepsy with unemployment. 
Drugs (polytherapy) were significantly associated with unemployment, employment and students 
in equal proportion. None of the other clinical characteristics significantly associate with 
employment status (p>0.05).  
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Among structural imaging techniques, none of them had an association with employment. 
Structural abnormalities like MTS had a significant association with unemployment (37.09%).  
Also, patients who did not show any structural abnormalities had 20.36% chance of 
unemployment. The side of lesion and EEG finding did not associate with employment. A 
Higher proportion of patients with mental retardation (40%) and MQ scores (48.36%) were 
significantly associated with unemployment. Patients with normal IQ scores (65.22%) and MQ 
scores (75.16%) were significantly associated with employment (65.22%). Normal BGT scores 
were significantly associated with employment (62.73%). The absence of anxiety (46.58%), 
depression (55.28%) and anxiety- depression (57.76%) was significantly associated with 
employment. 
 
 
5.    Inferences summary  
 
5.1.    Prevalence of intractable epilepsy  
The prevalence of intractable epilepsy in the adult population (21.05%) of the present 
study were comparable to the western studies (8,112), that considered Drug-resistant epilepsy 
(ILAE, 2010) criteria. Despite differences in definition, the prevalence of intractable epilepsy in 
this study was congruent to that of the western studies(5,7,112) in which the prevalence ranged 
from 15.6% to 22.5%. Higher frequency of patients with intractable epilepsy was observed in the 
age range of 16-20 years followed 26-30 years age range, which was similar to the results of a 
study that showed increased prevalence in 20-29 years (85), a hospital-based study in Singapore. 
Our results were not in congruence with results of a population-based study in north Italy (112) 
and shows increased prevalence in the age range of 35 to 54years.   Decreased prevalence was 
observed in the age range >60 years (1.38%) were similar to both the studies (85,112) that 
showed the reduced prevalence of intractable epilepsy  (> 55 years of age). There are no studies 
in India regarding the prevalence of intractable epilepsy especially using drug resistance epilepsy 
(ILAE, 2010) criteria. 
 
5.2.    Association of type of seizure with demographics, clinical characteristics and 
neuropsychological findings  
From the present study, it was observed the type of seizure ( a partial seizure) has a 
strong association with seizure semiology changes, MTS, DTWI abnormalities and low IQ 
scores. The type of seizure was not associated with any other variable considered for the study. 
These findings were consistent with several invitro and invivo research studies (40,85,113,114). 
 
5.3.     Association of Structural lesions with demographics, clinical characteristics and 
neuropsychological findings  
Among structural abnormalities, MTS was associated with a side of the lesion in MRI 
and DTWI(8,10). Neoplastic and nonneoplastic lesions were significantly associated with CT 
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results. MTS was associated with low IQ scores and anxiety and depression(115). Structural 
lesion in patients with intractable epilepsy did not show any significant association with other 
demographic and clinical characteristics. The quality of life is invariably poor in patients with 
intractable epilepsy (structural lesions).  
 
5.4.    Association of education and occupation with demographics, clinical characteristics, 
structural lesions and neuropsychological findings 
Early age seizure onset, longer duration of seizure, polytherapy, low IQ and MQ scores 
were significantly associated with low education levels. Similar to education unemployment was 
significantly associated with early age of seizure onset, polytherapy, MTS, low IQ scores and 
MQ scores. Patients without any schooling, elementary or high school level of education were 
associated with unemployment. Recurrent attacks of seizure from childhood and polytherapy 
lead to permanent damage to the brain structures particularly memory, language and emotional 
neural network.  This would result in impaired cognitive function, learning disability and 
behavioural disturbances leading to a reduced level of education and employment in intractable 
epilepsy patients (89,116–119). 
 
5.5.    Localizing side of abnormality across various radio imaging techniques and EEG 
CT and MRI could identify the same side of the lesion in more than 80% of patients. 
Even though MRI was abnormal in patients with intractable epilepsy, DTWI could reveal 
microstructural white matter abnormalities in a significant proportion of patients(71,72,76,79). 
Moreover, patients showing a localised lesion in one hemisphere using MRI showed the same 
side or bilateral white matter abnormalities in DTWI indicating large neural network 
involvement (71,72,75,77,78,80). Less proportion of patients with a focal lesion in right or left 
hemisphere in MRI showed similar hemispherical lateralization in interictal EEG. A significant 
association was observed in bilateral lesions in MRI with bilateral abnormalities in EEG(107).  A 
significant proportion of patients with bilateral microstructural changes in DTWI showed 
bilateral EEG abnormalities.  
 
5.6.    Sensitivity of radio imaging techniques and EEG 
From our study, it was observed that CT scan is more sensitive in identifying non-
specific lesion, neoplastic – non-neoplastic lesions.  MRI results were more associated MTS and 
MCDs. Interestingly it was observed that a small group of patients who did not have any lesions 
in CT and MRI but showed microstructural abnormalities in DTWI (71,72). Any one of the 
neuroimaging techniques is not sufficient to reveal the neural network involved in epilepsy. The 
combination of tests or a test battery approach including CT, MRI, DTWI and EEG could help us 
to trace out the neural network in intractable epilepsy. Our study showed 6.13% of intractable 
epilepsy patients without any structural abnormalities in the brain using conventional CT, MRI, 
DTWI and EEG. Among patients who did not show any structural lesion, few of them had 
metabolic encephalopathy (Mitochondrial cytopathy, glute1 deficiency disorder). Patients whose 
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conventional radio imaging including DTWI could not demonstrate any structural abnormalities; 
higher Tesla MRI may help in identifying neural network or tissue pathology.  
 
 
6.    Conclusion 
 From the present study it was found that the prevalence of intractable epilepsy in our 
population is 21.05 % using ILAE criteria. 
 Intractable epilepsy being a heterogeneous group with varying clinical characteristics, 
neuropsychological manifestations affecting their education, employment and quality of life. 
 It was observed that wide range patients with various structural abnormalities present with 
intractable epilepsy were noted from this research. 
 Conventional CT and MRI could identify the structural lesion in 80% of patients. Patients 
who do not show any lesion in CT, MRI may show microstructural white matter 
abnormalities in DTWI. In patients whom conventional radio imaging including DTWI could 
not demonstrate any structural abnormalities, higher Tesla MRI may help in identifying 
neural network or tissue pathology.  
 Also a small percentageof patients (6.13%) without any structural abnormalities in the 
investigation carried out do present with intractable epilepsy is still a clinical conundrum.  
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